diabetes glp-1 vs sglt2 Inhibitors vs. Agonists to Treat the Heart, the Kidneys and the Brain SGLT2 inhibitors vs GLP-1 receptor

Each of these medications works by enhancing satiety and reducing appetite, but they vary in administration frequency and potency, allowing for tailored treatment plans

Focus on enhanced permeation technologies for better absorption

Whilst extracellular A plaques, NFT, inflammation in the form or reactive astrocytes and microglia, and neuronal loss are all consistent pathological features of AD, a mechanistic link between these factors is yet to be clarified

As a result, type 2-dependent cytokines (IL-4, IL-5, and IL-13) induce, maintain, and amplify allergic inflammation, sustained by eosinophilic infiltration of target tissues [32]